Pituitary adenylate cyclase–activating polypeptide is reduced in Alzheimer disease

OBJECTIVES: There is growing evidence that pituitary adenylate cyclase–activating polypeptide (PACAP) is associated with Alzheimer disease (AD) pathology in animal models, but human studies are needed. METHODS: We studied the brains of patients with pathologically confirmed late-onset AD and age-mat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Han, Pengcheng, Liang, Winnie, Baxter, Leslie C., Yin, Junxiang, Tang, Zhiwei, Beach, Thomas G., Caselli, Richard J., Reiman, Eric M., Shi, Jiong
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4032204/
https://ncbi.nlm.nih.gov/pubmed/24719484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000417
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items